<?xml version="1.0" encoding="UTF-8"?>
<svg height="762.505" width="553.10644725" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="78.938" x="65.594,70.042,74.49,78.93799999999999" y="752.505" style="fill:#171615;font-family:RPCELK+Frutiger-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">982 </text>
  <text x="329.052,334.252,336.059,339.673,343.287,346.901,350.515,352.322,355.572,359.186,362.436,364.243,368.579,372.193,374.357,377.971,381.585,383.75,386.278,388.085" y="752.505" svg_rhmargin="389.892" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:6.5px;font-style:NORMAL;font-weight:normal;">© 2018 The Authors. </text>
  <text x="389.892,393.864,397.114,400.728,403.614,406.864,409.028,410.835,416.614,419.864,423.478,424.921,427.807,429.25,432.864" y="752.505" svg_rhmargin="436.114" style="fill:#171615;font-family:IERCPC+Frutiger-LightItalic;font-size:6.5px;font-style:ITALIC;font-weight:normal;">Cancer Medicine</text>
  <text y="752.505" svg_rhmargin="539.939" x="437.921,441.535,445.149,448.763,450.206,451.649,454.177,457.792,461.042,464.656,466.463,470.077,472.963,474.77,476.934,480.548,484.162,487.776,489.583,495.875,497.318,498.761,502.011,504.897,506.704,511.04,512.847,516.097,519.711,523.325,525.853,527.66,530.546,532.711,536.325,538.132" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:6.5px;font-style:NORMAL;font-weight:normal;">published by John Wiley &amp; Sons Ltd. </text>
  <text x="501.784,505.624,507.709,509.794,514.377,516.042,520.212,522.297,526.047,528.544,530.629,534.379,536.044" y="65.11699999999996" svg_rhmargin="538.129" style="fill:#171615;font-family:KHQORY+Frutiger-Light;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Y. Xin et al.</text>
  <text x="65.592,72.672,76.842,79.759,83.929,86.427,86.427,90.597,95.179,99.349,101.434,105.184,108.102,110.187,113.104,115.189,119.772,122.689,124.774,132.274,136.857,141.304,145.474,147.559,151.729,153.814,158.397,161.314,163.4,167.57,174.65,178.82,180.905,185.075,189.657,194.24,196.325,203.825,208.407,212.855" y="65.11699999999996" svg_rhmargin="217.025" style="fill:#171615;font-family:LGAUFW+Frutiger-Roman;font-size:7.5px;font-style:NORMAL;font-weight:normal;">Meta- analysis of WBRT Plus TMZ and WBRT</text>
  <text x="65.594,69.555,74.619,78.609,86.437,91.348,94.284,99.347,103.337,106.824,110.966,115.982,120.228,122.413,124.95,128.465,133.025,136.54,138.82,141.005,143.541,150.828,155.739,162.18,166.17,170.512,174.502,177.988,180.268,182.453,184.99,187.925,192.989,196.979,199.16400000000002,201.7,205.69,208.493,213.689,217.651,221.793,225.754,230.001,232.186,234.722,239.634,242.436,244.621,247.158,250.093,255.157,259.147,262.519,266.509,268.694,271.231,274.166,277.653,281.795,286.811,289.338" y="94.96199999999999" svg_rhmargin="292.806" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">chemotherapy [3]. However, the efficacy of these tradi-</text>
  <text x="65.594,68.529,71.056,75.968,81.155,85.297,87.691,89.876,91.975,94.911,98.397,102.387,106.529,109.465,117.293,121.283,126.47,129.405,132.778,134.963,137.062,139.589,144.776,146.961,149.061,153.953,157.44,161.582,164.109,169.296,171.481,173.58,181.408,185.398,188.334,192.476,195.848,198.784,202.926,206.298,210.288,213.661,215.846,217.945,220.472,223.845,226.03,228.129,233.145,238.057,242.968,246.455,248.735,250.92000000000002,253.019,258.776,263.84,267.83,271.316,275.306,278.109,283.02,286.507,290.497,292.777" y="106.96100000000001" svg_rhmargin="294.962" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">tional treatments in brain metastases is poor. Therefore, </text>
  <text x="65.594,68.529,73.593,77.583,81.069,85.059,87.244,88.845,91.372,94.744,96.929,98.535,102.677,107.864,110.049,111.65,116.78,120.266,124.598,128.588,133.775,136.711,138.89600000000002,140.501,145.688,149.678,153.668,158.684,160.869,162.475,165.41,170.322,172.507,174.112,179.128,183.118,187.46,191.45,193.844,198.755,203.771,205.956,207.562,212.749,216.739,223.18,225.365,226.97,230.343,233.278,236.765,240.907,243.842,247.832,252.164,254.691,258.681,262.054,264.239,265.844,268.647,273.558,277.045,279.23,280.835,283.771,288.834,292.824" y="118.95899999999995" svg_rhmargin="295.009" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">there is an urgent need to develop new strategies for the </text>
  <text x="65.594,68.529,72.016,76.006,80.148,83.083,90.911,94.901,100.088,103.024,105.209,107.394,112.305,115.108,117.293,119.478,124.37,127.857,131.999,134.526,139.713,141.898,144.083,151.911,155.901,158.836,162.978,166.351,169.286,173.428,176.801,180.791,184.163,186.348,188.533,191.336,194.822,199.734,207.562,209.747,211.932,218.971,223.493,229.754,234.798,241.059" y="130.95799999999997" svg_rhmargin="243.339" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">treatment of brain metastases from NSCLC.</text>
  <text x="75.094,80.756,84.651,92.384,97.2,101.01,105.826,108.125,112.942,120.675,123.107,128.028,131.923,134.108,135.832,139.252,144.914,153.302,158.898,162.318,164.50300000000001,166.227,168.659,171.937,174.122,175.846,179.893,182.078,183.807,187.084,190.979,194.846,199.662,204.754,209.675,213.048,213.043,217.28,221.175,226.267,230.162,233.554,237.601,240.441,242.873,247.69,252.782,254.967,256.691,260.738,263.037,267.597,271.748,274.047,278.094,280.935,283.367,288.459,292.791" y="142.95600000000002" svg_rhmargin="294.976" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Temozolomide (TMZ) is a second- generation alkylating </text>
  <text x="65.594,69.641,73.878,77.773,82.865,85.705,87.89,91.32,97.666,100.098,105.019,108.914,111.213,115.364,117.549,120.974,126.009,129.286,133.181,138.102,140.287,143.712,146.42,151.236,154.628,156.813,160.242,163.083,166.474,170.369,174.416,177.257,179.689,184.781,189.018,191.203,194.632,199.43,202.821,206.868,209.3,214.392,216.577,220.002,227.735,231.782,234.081,236.513,240.75,245.842,249.889,254.981,257.821,260.00600000000003,263.431,266.272,271.307,279.04,283.856,287.248,290.525,292.804" y="154.95500000000004" svg_rhmargin="294.989" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">agent widely used for treating brain malignant tumors. </text>
  <text x="65.594,71.256,79.644,85.24,87.425,89.277,93.172,98.264,101.105,105.0,108.391,111.669,113.854,115.706,118.547,123.515,127.41,129.595,131.448,135.314,139.209,144.301,147.142,150.533,154.58,156.879,159.064,160.917,166.009,169.904,173.295,177.542,182.358,187.393,190.671,192.856,194.708,197.986,202.137,205.415,208.255,212.15,219.883,222.068,223.921,227.341,233.506,240.451,244.878,248.298,250.483,252.335,256.23,260.277,263.555,265.987,268.286,272.437,274.622,276.807,278.66,282.707,287.799,292.814" y="166.95299999999997" svg_rhmargin="294.999" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">TMZ enters the central nervous system (CNS) easily, and </text>
  <text x="65.594,68.026,70.866,74.144,76.32900000000001,79.093,84.014,86.313,90.36,93.638,101.371,105.418,107.60300000000001,110.367,114.234,119.05,124.142,128.009,131.904,136.996,139.836,143.228,147.275,150.115,152.547,157.364,162.456,165.733,167.918,170.683,174.73,178.121,182.016,184.201,186.966,189.398,194.49,198.356,201.748,205.643,209.69,212.967,216.862,221.783,223.968,226.733,230.628,234.675,237.952,240.384,242.683,246.835,249.02,251.205,253.969,257.864,262.956,267.925,271.972,277.064,280.93,283.362,288.454,292.786" y="178.952" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">its plasma concentrations are increased easily, enhancing </text>
  <text x="65.594,68.434,73.403,77.298,79.483,81.943,85.99,91.082,93.923,96.355,99.195,104.23,111.963,116.78,120.171,122.35600000000001,124.817,128.864,132.73,135.571,138.003,142.249,144.681,147.522,151.673,153.858,156.319,159.739,164.204,168.859,173.324,176.744,178.929,181.114,183.574,189.236,194.205,198.1,200.285,202.745,210.478,214.525,216.957,222.049,224.234,226.695,230.742,235.663,239.909,243.804,247.196,250.473,254.368,256.553,259.014,262.405,266.3,270.347,274.214,277.054,279.486,284.303,289.395,292.767" y="190.95000000000005" svg_rhmargin="294.952" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">the antitumor activity [4–6]. The main adverse reactions </text>
  <text x="65.594,68.026,73.118,76.984,79.283,84.318,89.239,93.134,94.892,99.984,104.031,109.066,112.343,116.238,120.285,122.47,124.228,128.474,133.291,141.024,143.456,146.296,148.728,153.82,158.057,160.242,162.0,164.707,168.754,171.595,174.027,178.264,183.299,187.194,189.379,191.136,195.183,200.275,205.196,206.954,211.922,215.817,223.55,227.597,230.438,235.254,237.553,242.37,246.607,249.039,252.905,254.663,258.054,261.949,265.227,270.148,274.964,280.056,283.334,287.229,290.506,292.785" y="202.94899999999996" svg_rhmargin="294.97" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">include nausea, vomiting, fatigue, and hematologic responses, </text>
  <text x="65.594,71.94,76.908,79.34,83.207,88.175,90.36,91.681,95.547,99.594,104.686,106.87100000000001,108.192,112.989,116.884,119.069,120.39,124.256,129.073,134.165,137.005,140.397,145.213,147.512,149.811,153.706,158.627,160.812,162.133,168.479,170.911,173.751,178.72,180.905,182.225,185.503,190.319,198.052,201.947,204.132,205.453,210.374,213.765,218.8,223.037,226.315,228.5,230.685,232.005,237.667,246.056,251.651,253.836,255.157,259.023,263.84,271.573,276.37,278.802,283.894,287.789,292.804" y="214.947" svg_rhmargin="294.989" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">which can be controlled with some drugs. TMZ combined </text>
  <text x="65.594,71.94,74.372,77.212,82.181,84.366,85.002,88.394,92.441,97.362,99.794,103.841,106.681,109.113,113.93,119.022,121.20700000000001,121.843,124.684,129.652,133.547,136.939,140.986,145.907,150.058,152.243,152.88,156.746,160.793,165.885,168.07,168.707,173.504,177.399,179.584,180.221,185.256,188.533,192.428,197.349,199.534,200.171,203.011,207.828,210.013,210.649,213.49,216.881,220.776,224.823,227.664,229.849,230.485,235.577,239.472,245.818,248.117,252.269,254.454,255.09,260.011,262.443,266.49,270.727,275.819,280.636,283.913,287.808,292.824" y="226.94600000000003" svg_rhmargin="295.009" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">with radiation therapy can be used to treat newly diagnosed </text>
  <text x="65.594,70.515,72.814,76.709,81.525,89.258,94.075,97.466,102.387,107.356,109.788,113.654,115.839,118.347,122.584,124.883,127.315,132.132,136.929,139.228,143.275,146.553,149.393,154.21,161.943,165.99,168.175,170.683,173.523,178.558,186.291,191.108,194.499,197.777,199.962,202.47,207.286,210.678,212.863,215.371,218.762,222.657,226.524,231.559,234.95,238.342,242.237,247.329,250.169,252.354,254.862,262.595,266.642,268.941,271.373,275.61,280.702,284.749,289.841,292.776" y="238.94399999999996" svg_rhmargin="294.961" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">pleomorphic glioblastoma tumors or recurrent malignant </text>
  <text x="65.594,69.831,72.13,74.562,79.378,87.111,91.158,94.436,96.621,98.758,103.964,108.011,110.852,113.284,117.179,122.271,125.111,128.389,130.526,135.495,139.542,143.788,147.683,149.821,154.058,158.874,163.691,168.612,170.749,173.59,178.406,180.705,184.6,187.992,192.039,197.131,200.997,204.892,207.03,211.846,214.554,216.691,222.353,230.742,236.337,238.475,242.522,247.614,252.535,254.672,257.104,259.945,262.082,266.129,269.996,274.964,277.396,281.291,285.538,289.433,292.805" y="250.94299999999998" svg_rhmargin="294.99" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">gliomas. Patients have good tolerance of TMZ and it achieves </text>
  <text x="65.594,69.831,74.647,79.464,84.385,86.57000000000001,88.66,92.526,94.825,97.257,102.349,104.781,108.648,112.695,114.994,117.179,119.269,123.164,125.871,130.973,134.839,138.886,142.753,146.904,149.089,151.274,153.364,155.796,163.529,168.45,171.842,176.658,180.905,183.337,188.429,192.666,194.851,196.941,201.862,205.909,208.749,211.181,215.076,220.168,223.009,225.194,227.284,232.053,237.088,241.135,243.434,245.866,248.706,252.858,255.043,257.133,261.949,264.657,266.842,268.932,271.231,273.663,276.37,280.265" y="262.94100000000003" svg_rhmargin="282.545" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">good clinical efficacy, improving patient quality of life.</text>
  <text x="75.094,81.221,84.157,86.342,88.242,93.258,96.744,100.734,104.107,108.097,113.284,116.219,118.499,120.684,122.584,126.726,128.911,130.811,133.614,137.604,144.045,146.23,148.13,151.616,155.758,160.945,165.961,170.873,178.701,181.228,185.132,189.122,194.138,196.323,198.223,202.185,207.096,212.283,215.219,218.705,223.617,226.011,228.405,232.395,237.411,239.596,241.496,244.431,247.918,250.445,254.587,256.981,260.353,262.538,264.438,267.953,273.862,280.123,285.88,289.252,292.767" y="274.94000000000005" svg_rhmargin="294.952" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">At present, a few randomized controlled trials (RCTs) </text>
  <text x="65.594,70.657,74.799,79.141,83.131,85.316,86.608,89.98,95.044,99.955,106.396,111.583,113.768,115.06,117.996,123.059,127.201,130.137,132.322,133.614,139.371,147.854,153.545,155.73,157.022,160.983,165.895,173.723,178.615,181.142,186.329,190.319,195.335,197.52,198.812,205.253,207.78,210.716,215.779,217.964,219.256,225.697,230.761,235.672,238.066,242.056,245.524,245.524,250.416,253.903,258.045,260.572,265.759,267.944,269.236,272.722,276.864,281.88,284.407,289.319" y="286.938" svg_rhmargin="292.787" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">have shown that TMZ combined with whole- brain radio-</text>
  <text x="65.594,68.529,73.593,77.583,81.069,85.211,90.227,94.474,96.659,98.559,102.074,111.042,116.609,122.518,128.275,131.79,133.975,135.875,139.836,143.978,149.165,151.35,153.25,156.623,159.15,163.482,168.669,171.196,176.392,180.354,184.496,189.683,192.618,195.012,199.259,201.444,203.344,205.871,213.699,218.715,222.201,227.113,231.454,235.444,237.629,239.529,242.465,247.528,251.518,253.703,255.603,259.09,263.08,270.908,273.435,276.807,280.18,282.707,287.618,292.805" y="298.936" svg_rhmargin="294.99" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">therapy (WBRT) can significantly improve the remission </text>
  <text x="65.594,69.08,73.222,76.158,80.148,82.333,85.477,90.389,93.191,95.376,98.521,103.413,106.9,111.042,113.569,118.756,120.941,124.085,131.913,135.903,138.839,142.981,146.353,149.289,153.431,156.803,160.793,164.166,166.351,169.495,174.407,177.209,179.394,182.539,189.578,194.1,200.361,205.405,211.666,213.946,216.131,219.275,222.467,227.654,229.839,232.984,237.126,242.142,247.158,249.685,252.62,255.147,260.059,265.246,267.526,269.711,272.855,278.612,287.096,292.786" y="310.935" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">rate of brain metastases of NSCLC. In addition, TMZ </text>
  <text x="65.594,69.555,73.697,78.884,81.069,82.969,86.959,92.146,97.21,101.352,106.539,110.5,114.49,116.675,118.575,121.511,126.574,130.564,132.749,134.649,138.136,142.278,147.294,149.821,154.732,158.105,162.095,167.282,170.654,173.181,176.117,178.644,182.548,185.075,190.262,194.594,196.779,198.679,202.669,205.472,208.274,212.264,216.226,219.161,221.346,223.246,228.158,230.96,233.145,235.045,244.013,249.58,255.489,261.246,263.431,265.331,268.846,273.406,276.921,279.201,281.386,283.286,289.414,292.786" y="322.934" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">can enhance the radiosensitizing effect of WBRT [7]. As </text>
  <text x="65.594,68.529,73.593,77.583,80.955,84.945,87.13,89.923,95.832,102.093,107.85,111.222,113.407,116.2,121.112,126.299,128.693,132.939,135.124,137.917,142.059,147.246,151.388,153.782,158.029,161.933,165.923,170.939,173.124,175.917,180.059,182.244,185.037,188.524,192.514,194.908,199.05,201.985,204.512,208.854,212.844,215.238,219.484,221.669,224.462,227.835,235.663,239.805,242.199,244.593,246.778,249.571,254.758,259.888,267.716,272.608,276.598,280.085,282.27,285.063,289.974,292.777" y="334.932" svg_rhmargin="294.962" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">these RCTs only analyzed a relatively small number of </text>
  <text x="65.594,70.61,74.752,77.687,80.214,84.204,89.391,92.327,95.699,97.884,100.459,104.601,109.788,114.804,116.989,119.563,127.391,132.303,135.675,138.611,140.796,143.37,149.811,153.801,157.288,161.278,163.463,166.037,169.524,173.514,176.449,179.936,184.847,188.22,193.236,197.226,201.187,204.123,206.65,210.991,214.981,217.166,219.741,223.113,226.049,231.179,236.195,238.722,242.712,246.084,248.364,250.549,253.124,255.518,259.66,263.146,267.478,271.468,274.936,274.926,278.299,282.26,286.402,288.796,292.786" y="346.931" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">patients and most were retrospective studies, large- scale </text>
  <text x="65.594,70.61,74.752,77.687,81.829,84.014,85.463,89.605,93.091,97.081,99.266,100.715,105.902,109.892,113.882,118.898,122.888,127.904,130.089,131.538,134.473,139.385,141.57,143.019,146.98,151.892,157.079,162.275,165.762,173.59,175.775,177.223,180.159,185.222,189.212,191.397,192.846,196.836,199.639,202.441,206.431,210.393,213.328,215.855,220.197,224.187,229.374,233.364,236.736,240.109,242.294,243.747,248.659,251.461,253.64600000000002,255.095,258.031,263.094,265.621,268.994,271.17900000000003,272.627,276.589,281.5,289.328" y="358.929" svg_rhmargin="292.796" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">data are needed to confirm the effectiveness of this com-</text>
  <text x="65.594,70.486,73.013,78.2,82.342,85.278,87.805,92.716,97.903,100.08800000000001,102.81,105.745,110.809,114.799,118.285,122.427,127.443,131.69,133.97,136.155,138.881,144.638,149.702,153.692,155.877,158.603,162.745,165.272,173.1,175.285,178.012,182.923,185.726,187.911,190.637,193.573,198.636,201.163,204.536,206.721,209.447,217.275,221.265,224.201,228.343,231.81,231.787,235.929,241.116,245.258,247.652,251.898,255.271,257.798,261.17,263.355,266.082,272.523,276.665,280.037,282.222,284.949,287.884,292.796" y="370.928" svg_rhmargin="294.981" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">bination therapy. The aim of this meta- analysis was to </text>
  <text x="65.594,69.555,74.467,82.295,87.311,91.453,94.939,98.929,101.114,103.917,106.852,111.916,115.906,118.09100000000001,120.893,124.883,127.686,132.882,136.844,139.371,143.361,148.548,152.509,156.756,158.941,161.743,165.885,171.072,176.088,178.273,181.076,185.218,190.234,194.575,198.565,202.052,205.424,209.414,211.599,214.402,217.888,221.878,226.02,229.982,232.917,235.444,240.356,245.543,248.915,251.1,253.903,258.814,261.617,263.802,266.604,275.572,281.139,287.048,292.805" y="382.926" svg_rhmargin="294.99" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">compare the efficiency and adverse reactions of WBRT </text>
  <text x="65.594,70.61,73.004,78.134,81.506,83.691,85.838,91.595,100.079,105.769,107.95400000000001,110.101,116.542,119.069,122.005,127.068,129.253,131.4,140.368,145.935,151.844,157.601,159.786,161.933,166.075,168.469,173.381,178.568,182.558,184.743,186.89,189.692,194.604,198.09,200.275,202.422,205.358,210.421,214.411,216.596,218.743,221.679,225.165,229.155,233.297,236.233,244.061,248.051,253.238,256.173,258.358,260.505,265.417,268.219,270.404,272.551,277.444,280.93,285.072,287.599,292.786" y="394.925" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">plus TMZ with WBRT alone for the treatment of brain </text>
  <text x="65.594,73.422,77.412,80.347,84.489,87.862,90.797,94.939,98.312,102.302,105.674,107.85900000000001,110.044,112.847,116.333,121.245,129.073,131.258,133.443,140.482,145.004,151.265,156.309,162.57" y="406.923" svg_rhmargin="164.85" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">metastases from NSCLC.</text>
  <text x="65.594,77.094,84.12,89.226,96.253,101.359,105.2,112.226,116.067,121.817,125.336,132.363,140.033,147.715,151.234,162.734,169.761,174.867,182.537,190.219,197.901" y="436.962" svg_rhmargin="203.651" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:11.5px;font-style:NORMAL;font-weight:bold;">Materials and Methods</text>
  <text x="65.594,73.179,79.136,83.465,89.423,92.406,97.281,103.794,110.297,114.626,119.501,125.459" y="460.962" svg_rhmargin="130.334" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Data sources</text>
  <text x="65.594,74.562,78.552,80.49,83.862,87.852,91.994,95.481,99.442,104.506,108.496,113.512,115.45,118.385,123.449,127.439,129.377,138.345,142.487,147.674,150.476,154.618,159.805,164.137,166.075,173.001,177.143,180.078,184.22,189.113,193.255,196.627,200.617,202.897,204.835,210.136,215.266,220.159,228.642,232.632,237.648,239.928,241.866,244.802,249.865,253.855,255.793,262.054,266.965,270.927,275.99,279.477,283.619,288.806,292.796" y="478.962" svg_rhmargin="294.981" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">We searched the Wanfang Database, PubMed, the Cochrane </text>
  <text x="65.594,70.638,73.165,78.058,81.544,85.686,89.173,93.419,95.699,97.552,106.035,110.025,115.041,117.435,119.962,125.149,129.139,131.419,133.272,137.414,142.601,147.617,149.469,154.732,157.126,160.062,164.973,170.16,172.013,177.58,179.86,181.712,186.234,189.17,193.16,198.176,203.239,207.229,212.416,215.789,217.641,223.902,228.813,236.641,241.657,245.799,250.986,255.233,257.085,260.6,265.863,271.43,275.952,282.213,289.29,292.805" y="490.961" svg_rhmargin="294.99" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Library, Medline, and Elton B. Stephens Company (EBSCO) </text>
  <text x="65.594,70.724,74.096,76.623,81.81,86.142,88.213,91.149,96.212,100.202,102.273,106.928,110.918,115.165,121.606,126.517,130.004,135.02,138.392,140.463,144.577,147.512,151.502,159.33,164.242,168.146,173.058,175.452,180.363,188.191,190.718,195.734,199.724,201.795,208.873,214.782,216.853,222.61,231.093,236.784,240.897,242.968,249.096,256.135,263.061,265.132,269.245,272.732,276.874,281.89,284.417,289.328" y="502.959" svg_rhmargin="292.796" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">using the keywords “temozolomide OR TMZ” AND “radio-</text>
  <text x="65.594,68.529,73.593,77.583,81.069,85.211,90.227,94.474,98.587,100.772,103.841,109.968,117.008,123.933,126.11800000000001,129.187,133.3,138.193,141.679,145.821,148.348,153.535,155.72,158.789,166.617,170.607,173.542,177.684,181.057,183.992,188.134,191.507,195.497,198.869,202.983,205.168,208.236,214.364,221.403,228.329,230.514,233.582,237.696,242.883,247.794,252.981,256.449,256.458,259.831,267.659,271.801,274.195,276.589,280.056,280.056,284.018,288.008,290.402,292.796" y="514.9580000000001" svg_rhmargin="294.981" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">therapy” AND “brain metastases” AND “non- small- cell </text>
  <text x="65.603,67.997,73.127,78.314,82.646,84.831,85.411,89.372,93.514,98.701,102.663,106.653,110.139,112.324,112.904,119.981,125.89,128.075,128.655,135.694,140.216,146.477,151.521,157.782,160.062,164.175,166.36,166.94,172.697,177.76,181.75,183.935,184.515,189.531,194.661,199.553,201.947,204.474,208.436,212.578,215.513,218.04,222.952,228.139,230.324,230.903,235.919,240.061,242.997,246.987,250.359,252.544,253.124,259.565,263.555,267.041,271.031,273.216,273.796,276.598,280.085,284.996,292.824" y="526.956" svg_rhmargin="295.009" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">lung cancer OR NSCLC.” The publication dates were from </text>
  <text x="65.603,70.163,72.348,75.103,78.238,82.38,87.567,92.697,96.839,100.326,104.572,106.757,109.512,114.072,118.632,123.192,127.752,129.93699999999998,132.692,135.628,140.539,142.724,145.479,150.039,152.224,154.979,158.114,163.244,168.431,172.421,174.606,177.361,181.921,186.481,191.041,195.601,197.786,200.541,206.982,209.509,212.445,217.508,219.693,222.448,227.635,232.547,234.732,237.487,240.973,244.963,248.336,251.271,254.758,257.285,261.246,264.182,266.709,271.62,276.807,280.18,282.365,285.12,287.647,292.834" y="538.9549999999999" svg_rhmargin="295.019" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">1 January 2002 to 1 June 2017 with no restrictions in </text>
  <text x="65.603,67.997,72.139,77.326,81.658,86.788,90.93,95.262,99.252" y="550.953" svg_rhmargin="101.532" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">language.</text>
  <text x="65.594,71.551,75.88,82.383,88.896,94.853,97.837,102.712,108.669,111.926,117.883,122.758,127.087,130.343,136.856" y="580.962" svg_rhmargin="143.359" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Study selection</text>
  <text x="65.594,71.351,76.414,80.404,82.589,84.926,87.453,92.64,96.602,98.996,104.126,107.498,110.025,114.937,120.124,122.309,124.646,128.607,132.094,134.621,137.556,141.546,145.033,147.56,151.702,153.887,156.224,159.026,163.938,167.424,169.609,171.946,174.882,179.945,183.935,186.12,188.457,194.366,200.627,206.384,209.756,211.941,214.278,220.719,224.709,228.196,232.186,234.466,236.651,238.988,242.503,245.03,248.545,250.73,253.067,258.083,262.225,265.16,270.224,275.135,277.529,282.441,286.773,289.3" y="598.962" svg_rhmargin="292.768" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The inclusion criteria for the RCTs were: (i) pathologi-</text>
  <text x="65.594,69.555,73.697,76.091,78.485,82.732,84.917,87.434,91.396,96.307,101.494,106.691,110.177,118.005,121.995,127.011,129.196,131.714,138.753,143.275,149.536,154.58,160.841,163.026,165.543,169.685,174.872,179.888,182.073,184.591,189.607,192.134,196.276,200.608,205.795,210.706,214.079,218.069,223.085,225.27,227.787,232.68,236.166,240.308,242.835,248.022,250.207,252.725,260.553,264.543,267.478,271.62,274.993,277.928,282.07,285.443,289.433,292.805" y="610.961" svg_rhmargin="294.99" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">cally confirmed NSCLC and diagnosed brain metastases </text>
  <text x="65.594,72.035,74.562,77.497,82.561,84.74600000000001,86.56,90.522,95.433,103.261,108.277,113.407,116.343,120.333,125.349,127.534,129.348,132.284,137.195,145.023,149.935,154.267,157.753,161.895,166.911,171.975,176.221,178.406,180.221,183.736,189.996,195.753,199.268,201.453,203.268,208.179,211.666,213.851,215.665,223.493,227.635,231.967,237.154,241.144,244.08,246.607,250.568,252.75300000000001,254.568,258.054,262.044,265.417,270.328,275.515,279.657,284.844,288.806,292.796" y="622.9590000000001" svg_rhmargin="294.981" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">with computed tomography (CT) or magnetic resonance </text>
  <text x="65.594,68.121,75.949,80.091,84.423,86.95,92.137,96.469,98.654,100.083,103.598,112.082,117.991,121.183,124.698,126.978,129.16299999999998,130.597,134.112,136.639,139.166,142.681,144.866,146.301,150.443,154.775,158.765,163.781,165.966,167.4,172.312,176.653,180.643,184.13,186.315,187.749,192.309,196.869,199.054,200.489,204.735,208.725,212.867,216.354,219.726,222.006,224.191,225.626,229.141,231.668,234.195,236.722,240.237,242.422,243.852,247.338,251.48,256.496,259.023,263.935,266.87,271.934,275.924,279.41,283.552,288.568,292.815" y="634.958" svg_rhmargin="295.0" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">imaging (MRI); (ii) aged over 18 years; (iii) radiotherapy </text>
  <text x="65.594,69.736,74.923,79.939,82.333,86.294,91.358,95.348,103.176,108.087,111.023,116.086,120.076,123.563,127.705,132.721,136.967,139.361,142.297,147.208,149.602,153.592,157.079,161.221,166.408,170.369,174.359,176.639,179.033,182.548,185.075,189.417,192.932,195.326,199.316,203.771,208.787,212.777,216.739,219.674,223.664,228.68,231.074,233.468,235.995,238.798,242.788,245.723,248.25,256.078,260.068,262.462,267.374,270.176,272.57,280.398,285.31,288.796,292.786" y="646.956" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">and chemotherapy tolerance; (iv) expected lifetime of more </text>
  <text x="65.594,68.529,73.593,77.735,82.922,85.107,86.921,91.481,93.666,95.481,103.309,108.22,113.407,116.343,121.406,124.779,127.059,129.244,131.058,134.573,138.915,142.43,144.615,146.429,150.391,155.302,163.13,168.146,172.288,175.775,179.765,184.781,186.966,188.78,197.748,203.315,209.224,214.981,217.166,218.981,223.322,227.312,230.799,234.171,239.301,242.674,244.859,246.673,255.641,261.208,267.117,272.874,275.059,276.874,281.89,284.284,289.414,292.786" y="658.955" svg_rhmargin="294.971" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">than 3 months; (v) compared WBRT versus WBRT plus </text>
  <text x="65.594,71.351,79.834,85.525,87.805,89.99000000000001,92.175,96.317,101.504,106.52,108.705,110.89,114.405,118.746,121.273,124.788,126.973,129.158,132.645,136.635,141.651,146.562,150.049,152.984,156.974,161.99,164.175,166.36,169.733,174.863,177.665,182.862,186.823,189.35,193.34,198.527,201.463,203.648,205.833,210.849,214.991,217.926,222.068,224.25300000000001,226.438,231.35,236.537,238.722,240.907,245.818,250.948,253.884,257.845,262.757,270.585,274.575,277.947" y="670.953" svg_rhmargin="280.227" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">TMZ; and (vi) reported sufficient data on outcomes.</text>
  <text x="75.094,80.357,84.812,88.774,91.168,96.298,99.67,102.197,107.109,112.296,114.48100000000001,117.179,121.14,124.627,127.154,130.089,134.079,137.566,140.093,144.235,146.42000000000002,149.118,155.559,159.549,163.035,167.025,169.305,171.49,174.188,177.703,180.23,183.745,185.93,188.628,193.815,198.727,203.914,207.4,211.542,216.729,221.745,226.657,234.485,237.012,240.916,244.906,249.922,252.107,254.805,258.947,264.134,269.15,271.335,274.033,279.22,284.132,289.319" y="682.952" svg_rhmargin="292.787" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Exclusion criteria were: (i) nonrandomized and non-</text>
  <text x="65.594,69.555,71.949,74.476,79.663,82.19,86.152,90.294,92.688,94.873,96.421,100.383,105.294,110.481,113.417,116.903,121.815,124.209,126.603,130.593,135.609,137.794,139.342,142.278,145.764,148.291,152.433,154.827,158.2,160.48,162.665,164.213,167.728,170.255,172.782,176.297,178.482,180.031,182.966,186.453,188.98,193.122,195.516,198.888,201.073,202.622,209.063,211.59,214.525,219.589,221.774,223.322,231.15,233.677,237.05,240.422,242.949,248.136,252.468,254.653,256.202,261.218,265.36,268.295,272.437,274.717,276.902,278.451,282.593,287.78,292.796" y="694.95" svg_rhmargin="294.981" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">clinical controlled trials; (ii) trials with missing data; and </text>
  <text x="65.594,69.109,71.636,74.163,76.69,80.205,82.385,87.401,92.531,97.547,99.941,102.468,106.429,110.571,113.507,117.497,119.677,123.164,127.154,132.17,137.081,140.568,143.503,146.876,149.156,151.336,154.271,157.758,160.285,164.427,166.821,170.193,172.378,177.29,180.092,182.273,187.289,192.2,197.112,200.598,202.783,210.611,214.601,217.537,222.6,227.512,232.528,237.439,239.833,244.745,249.077,251.604,255.565,259.707,262.101,264.281,269.145,274.275,278.417,280.811,283.338,286.274,290.52,292.8" y="706.949" svg_rhmargin="294.985" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">(iii) duplicate reports, trials of poor methodological quality, </text>
  <text svg_rhmargin="180.544" x="65.594,69.736,74.923,79.939,82.124,84.309,87.244,90.731,93.258,97.4,99.794,103.166,105.351,107.536,113.977,116.504,119.44,124.503,126.688,128.873,133.785,138.677,143.019,145.546,150.457,155.587,158.96,161.145,163.33,168.222,170.749,174.891,178.264,180.544" y="94.94899999999996" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">and trials with obvious bias. </text>
  <text x="320.431,326.188,331.252,335.242,337.427,338.966,343.108,348.238,351.173,356.237,361.148,364.635,368.007,370.192,371.731,375.693,379.835,383.321,387.311,390.114,395.244,397.638,400.032,404.278,406.463,408.002,412.144,417.331,421.473,423.867,428.114,432.018,436.008,441.024,443.209,444.748,447.684,452.747,456.737,458.922,460.461,468.289,472.279,475.215,480.278,485.19,490.206,495.117,497.511,502.423,506.755,511.001,513.1859999999999,514.725,519.637,522.439,524.6239999999999,526.163,529.099,534.162,538.152" y="94.94899999999996" svg_rhmargin="540.337" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The authors carefully analyzed the methodology of the </text>
  <text x="310.931,315.073,318.56,321.495,324.022,327.984,330.378,334.368,337.74,339.925,342.177,345.112,350.024,352.209,354.46,357.833,361.823,364.217,368.207,372.168,375.104,377.289,379.54,382.476,387.539,391.529,393.714,395.966,400.83,405.96,410.102,412.496,415.023,420.219,424.209,429.225,431.41,433.662,439.571,445.831,451.588,454.961,457.241,459.426,461.677,470.645,473.172,476.108,481.171,483.356,485.608,488.543,493.607,497.597,499.782,502.033,506.688,510.678,514.925,521.366,526.277,529.764,534.78,538.152" y="106.94799999999998" svg_rhmargin="540.337" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">articles to select the qualified RCTs. With the keywords </text>
  <text x="310.931,316.061,319.434,323.424,328.44,330.72,332.90500000000003,334.9,339.46,344.02,346.205,348.2,353.216,357.358,362.374,366.364,369.85,373.223,375.408,377.403,380.918,385.478,390.038,392.223,394.218,396.745,401.932,404.117,406.112,412.372,417.436,419.963,425.15,429.14,432.512,436.502,438.687,440.682,444.824,450.011,455.027,457.212,459.207,463.767,468.327,470.512,472.507,475.034,480.221,482.406,484.401,489.664,494.851,499.183,501.577,504.104,507.477,512.54,516.055,518.2399999999999,520.235,526.676,530.666,534.153,538.143" y="118.94600000000003" svg_rhmargin="540.328" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">used, 91 papers (67 in Chinese and 24 in English) were </text>
  <text x="310.931,313.458,318.474,322.464,327.651,330.587,333.114,338.31,342.3,347.316,349.596,351.781,353.919,360.046,364.008,367.969,372.881,376.367,381.383,383.91,389.097,393.429,395.614,397.752,400.687,405.599,407.784,409.921,412.857,417.92,421.91,424.095,426.233,428.76,433.947,437.908,440.302,445.432,448.805,451.332,456.243,461.43,463.615,465.753,469.895,475.082,480.098,482.283,484.42,488.41,492.866,496.827,499.221,504.351,507.724,510.251,515.162,520.349,522.534,524.672,528.633,532.12,534.647" y="130.94500000000005" svg_rhmargin="538.115" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">identified. According to the inclusion and exclusion cri-</text>
  <text x="310.931,313.867,317.857,321.343,323.87,328.012,330.292,332.354,338.795,342.785,344.846,347.373,352.56,357.576,361.566,366.582,370.572,375.759,380.775,384.765,389.952,392.888,395.282,399.528,401.59,405.58,410.035,414.177,422.005,424.532,429.719,433.709,438.725,440.787,443.722,448.786,452.776,454.837,457.64,462.77,465.164,467.558,469.619,472.555,476.545,481.0,483.936,485.992,490.134,495.321,500.337,502.399,507.415,509.942,513.314,517.276,522.406,525.778,529.151,533.141,538.157" y="142.94299999999998" svg_rhmargin="540.342" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">teria, we independently examined the full text and discussed </text>
  <text x="310.931,314.921,319.063,323.025,328.088,330.273,332.458,336.6,340.087,343.022,345.549,349.511,351.905,355.895,358.08,360.265,363.2,368.112,372.444,376.434,379.369,384.433,388.423,391.909" y="154.942" svg_rhmargin="394.189" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">each article together.</text>
  <text x="310.932,318.518,324.475,328.804,334.761,337.745,343.702,349.659,353.988,358.317,364.275,369.15,373.479,376.735,383.248,389.751,392.735,398.692,405.195,411.708,414.692,419.567,425.524,432.027,436.356,442.86,448.817,453.692,456.948" y="184.962" svg_rhmargin="461.823" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Data extraction and synthesis</text>
  <text x="310.932,316.689,321.753,325.743,327.928,328.963,331.49,336.677,341.019,345.009,348.381,351.317,353.844,358.176,362.318,365.253,370.165,373.651,377.024,379.209,380.244,384.206,388.348,391.834,395.824,398.627,403.757,406.151,408.545,412.791,414.976,416.012,420.002,424.457,427.393,430.879,435.021,438.983,441.918,445.908,450.924,453.109,454.145,459.161,463.303,466.238,470.38,472.565,473.601,476.403,479.89,484.801,492.629,494.814,495.85,498.785,503.849,507.839,510.024,511.059,515.049,517.443,519.97,524.302,526.829,531.722,534.116,538.106" y="202.962" svg_rhmargin="540.291" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The investigators carefully extracted data from the eligible </text>
  <text x="310.932,314.305,317.24,322.37,327.386,329.913,333.903,337.276,339.556,341.741,343.508,350.433,354.575,357.511,361.653,363.838,365.605,368.132,373.319,377.28,379.674,384.804,389.82,393.81,398.826,401.011,402.778,405.714,410.777,414.767,416.952,418.719,423.906,428.048,435.876,439.866,442.051,443.818,448.73,451.532,453.717,455.484,458.42,463.483,467.473,469.658,471.425,476.622,480.108,483.481,486.416,488.601,490.368,494.51,499.64,502.576,507.639,512.551,516.037,518.317,520.502,522.269,526.516,530.506,534.648,538.134" y="214.961" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">studies. Data included the name of the first author, year </text>
  <text x="310.932,315.844,318.646,320.831,322.646,327.662,332.792,337.684,340.078,342.605,346.567,350.709,353.644,356.171,361.083,366.27,368.55,370.735,372.545,374.967,379.879,385.009,388.495,393.682,397.824,400.218,402.403,404.218,409.405,413.547,421.375,425.365,427.645,429.83,431.644,436.508,441.638,445.78,448.174,450.701,453.637,457.883,460.068,461.883,466.794,469.597,471.782,473.596,476.532,481.595,485.585,487.77,489.585,492.957,495.893,501.023,506.039,510.285,512.565,514.75,516.565,519.092,524.279,527.214,531.204,534.691" y="226.95899999999995" svg_rhmargin="538.159" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">of publication, journal name, quality of the study, inter-</text>
  <text x="310.932,315.274,319.264,324.451,327.386,329.913,334.825,340.012,342.292,344.477,347.878,353.065,358.195,366.023,370.915,374.905,378.392,380.577,383.978,388.889,391.692,393.877,397.278,402.294,406.436,409.371,411.898,415.888,421.075,424.011,427.383,429.568,432.969,435.496,440.683,442.868,446.269,449.205,454.268,458.258,460.443,463.844,467.217,470.152,475.282,480.298,484.545,486.825,489.01,492.411,497.427,502.338,505.711,509.853,514.185,518.175,520.3599999999999,523.761,527.903,533.09,538.106" y="238.95799999999997" svg_rhmargin="540.291" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">vention, number of patients in the study, dosage and </text>
  <text x="310.932,315.948,321.078,324.565,328.707,331.642,334.169,339.081,344.268,346.453,349.141,354.053,356.855,359.04,361.729,364.664,369.728,373.718,375.903,378.591,381.527,387.968,392.879,395.064,397.753,402.085,405.571,410.483,415.613,420.629,424.001,426.281,428.466,431.155,438.983,442.973,447.989,450.516,454.658,459.845,462.03000000000003,464.718,468.091,473.221,476.707,481.049,483.576,487.917,492.059,494.453,496.638,499.327,502.262,504.789,512.617,516.607,518.887,521.0719999999999,523.761,527.903,533.09,538.106" y="250.95600000000002" svg_rhmargin="540.291" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">duration of the two groups, median survival time, and </text>
  <text x="310.932,313.868,318.931,322.921,325.106,327.291,332.478,337.608,345.436,350.329,354.319,357.805,359.99,362.175,367.087,369.889,372.074,374.259,379.275,383.417,386.353,388.88,392.87,398.057,400.992,404.365,406.55,408.735,415.176,417.703,420.638,425.702,427.887,430.072,434.214,439.23,443.571,447.561,451.048,454.42,458.41,460.595,462.78,466.267,470.257,474.399,478.36,481.296,483.823,488.734,493.921,497.294" y="262.95500000000004" svg_rhmargin="499.574" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">the number of patients with adverse reactions.</text>
  <text x="310.932,320.682,326.64,329.896,336.399,339.383,345.896,352.399,356.728,361.603,368.116,377.866,383.823,387.616,392.491,396.284,399.267,405.225,411.728,418.241,421.224,430.974,436.932,442.889,447.764,454.267,458.596,464.553,468.346,473.221" y="292.962" svg_rhmargin="477.014" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Main outcome(s) and measure(s)</text>
  <text x="310.932,316.689,321.753,325.743,327.928,329.628,332.431,337.342,339.736,342.13,347.042,353.483,356.01,361.197,365.529,367.714,369.414,374.326,379.456,382.391,386.353,391.264,399.092,403.082,406.455,408.64,410.34,416.781,420.771,424.258,428.248,430.433,432.133,439.961,443.951,448.093,451.466,456.596,460.082,464.072,469.088,471.368,473.553,475.254,480.165,484.507,488.497,491.983,496.125,498.519,500.913,503.098,504.799,508.285,512.275,515.648,520.664,525.575,530.762,534.135,538.125" y="310.962" svg_rhmargin="540.31" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The following outcomes were measured: overall response </text>
  <text x="310.932,314.419,318.561,321.496,325.486,327.766,329.951,334.739,339.803,343.793,347.935,352.951,357.093,361.054,366.118,370.108,372.388,374.573,379.361,383.693,387.835,391.207,394.143,397.629,402.541,405.068,410.255,413.19,417.18,420.553,423.488,426.015,431.202,435.344,437.738,439.923,444.711,448.853,453.869,458.211,462.201,465.687,469.06,473.05,475.235,480.023,483.509,487.499,491.641,495.603,498.538,501.065,505.977,511.164,514.536,516.816,519.001,523.789,527.931,533.118,538.134" y="322.961" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">rate, headache, gastrointestinal adverse reactions, and </text>
  <text x="310.932,315.996,319.986,327.814,331.956,334.891,339.803,342.197,347.108,351.44,353.967,357.929,359.857,363.999,369.015,373.357,377.347,380.833,384.206,388.196,390.124,393.611,397.601,401.743,405.704,408.64,411.167,416.078,421.265,424.638,426.918,428.846,435.924,440.265,444.255,447.742,451.884,454.278,456.672,458.6,462.087,466.077,469.449,474.465,479.377,484.564,487.936,491.926,493.855,500.296,504.438,507.81,509.739,514.755,518.745,523.941,529.128,533.118,538.134" y="334.959" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">hematologic adverse reactions. Overall response was defined </text>
  <text x="310.932,315.074,318.447,320.632,324.451,328.412,333.324,341.152,346.168,348.562,352.552,355.487,359.477,361.662,365.481,368.968,372.958,376.33,381.346,386.258,391.445,394.817,398.807,400.992,404.811,408.953,414.14,419.156,421.341,425.16,430.176,434.318,437.805,440.74,443.267,447.409,449.803,451.988,455.807,459.294,463.284,466.656,471.672,476.584,481.771,485.143,489.133,491.318,495.137,501.578,506.642,509.169,513.13,518.194,520.3789999999999,524.198,530.639,534.781,538.153" y="346.958" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">as complete response and partial response which was </text>
  <text x="310.932,318.76,322.75,326.892,330.265,335.395,338.881,342.871,347.887,350.072,350.88,355.772,360.019,362.204,363.011,367.904,371.39,375.532,378.059,383.246,385.431,386.239,392.499,398.256,400.441,401.249,406.16,409.647,411.832,412.639,421.123,427.032,430.224,432.409,433.216,437.358,441.32,445.281,450.193,453.679,458.695,461.222,466.409,470.741,472.926,473.734,476.669,481.581,483.766,484.573,493.541,498.453,501.939,504.333,509.349,511.534,512.342,519.628,523.618,527.76,530.154,533.09,538.153" y="358.956" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">measured by brain CT or MRI according to World Health </text>
  <text x="310.932,318.01,321.496,325.828,329.97,335.157,337.684,341.589,345.731,348.666,351.193,356.105,361.292,363.477,364.755,368.716,372.203,374.73,377.665,381.655,385.142,387.669,391.811,394.091,396.276,397.553,403.31,408.222,412.677,415.204,419.166,421.693,424.628,428.875,431.06,432.337,438.778,442.92,446.292,448.477,449.755,453.745,458.086,462.228,464.622,469.752,473.894,476.83,480.82,485.836,488.021,489.299,493.441,497.402,501.364,506.275,509.762,514.778,517.305,522.492,526.823,529.0079999999999,530.286,533.222,538.133" y="370.955" svg_rhmargin="540.318" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Organization criteria. Toxicity was evaluated according to </text>
  <text x="310.932,313.868,318.931,322.921,325.106,330.16,337.2,341.342,344.277,346.804,351.716,356.903,361.045,363.439,365.624,370.678,376.938,381.08,386.267,390.229,394.219,397.705,399.89,404.944,408.136,413.323,416.696,419.631,422.158,425.094,430.224,433.159,437.149,439.334,444.388,450.649,455.56,463.388,471.216,476.128,481.315,483.5,488.554,494.311,498.301,501.787,509.615,512.142,517.329,522.241,524.635,529.546,533.878,538.125" y="382.953" svg_rhmargin="540.31" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">the National Cancer Institute Common Terminology </text>
  <text x="310.932,317.193,320.679,323.206,326.142,330.132,333.618,336.145,340.287,342.472,344.876,347.678,352.59,356.076,358.261,360.665,366.792,371.808,376.15,380.14,383.626,386.999,390.989,393.174,395.577,400.84,405.182,409.172,414.359,417.294,420.667,422.852,425.255,429.597,433.587,437.073,440.446,442.973,447.884,453.071,455.25600000000003,457.66,462.22,464.5,469.06,471.34,473.525,475.928,481.685,486.749,490.739,492.924,495.327,500.514,505.644,513.472,518.365,522.355,525.841,528.026,530.43,535.341,538.144" y="394.952" svg_rhmargin="540.329" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">Criteria for Adverse Events version 3.0. The number of </text>
  <text x="310.932,315.948,320.09,323.026,325.553,329.543,334.73,337.665,341.038,343.223,344.211,350.652,353.179,356.114,361.178,363.363,364.346,368.488,373.504,377.846,381.836,385.322,388.695,392.685,394.87,395.858,399.344,403.334,407.476,411.438,414.373,416.9,421.811,426.999,430.371,432.556,433.544,439.985,444.127,447.5,449.685,450.673,454.634,459.546,461.94,464.334,468.324,472.285,475.22,479.21,484.226,486.411,487.399,492.415,494.942,498.429,502.419,506.38,509.316,511.71,515.956,518.141,519.125,521.927,525.414,530.325,538.153" y="406.95" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">patients with adverse reactions was collected directly from </text>
  <text x="310.932,313.868,318.931,322.921,325.106,326.028,331.044,336.174,341.066,343.46,345.987,349.36,354.423,358.413,363.429,365.614,366.536,371.552,375.694,380.71,384.7,388.186,391.559,393.839,396.024,396.945,403.871,406.398,409.77,413.912,418.244,421.731,425.721,429.711,437.539,441.529,446.716,449.651,451.836,452.758,456.244,460.234,464.566,468.708,472.195,477.211,479.738,484.925,489.257,491.442,492.363,497.379,501.521,504.457,508.599,510.784,511.705,515.695,520.151,523.086,526.573,530.715,534.676" y="418.949" svg_rhmargin="538.144" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">the published papers. Disagreement regarding data extrac-</text>
  <text x="310.932,313.868,316.395,321.306,326.493,328.678,331.984,338.425,342.567,345.94,348.125,351.431,354.917,358.907,362.28,367.191,369.585,373.927,377.917,382.933,385.118,388.424,393.316,397.563,399.748,403.054,408.07,410.597,413.969,417.931,423.061,426.433,429.806,432.333,437.244,442.431,444.616,447.922,452.064,457.251,462.267,464.452,467.758,471.72,476.631,481.818,485.191,489.181,494.368,497.74,502.87,506.243,508.428,511.734,515.876,523.704,528.615,533.802,538.134" y="430.947" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">tion was resolved by discussion and consensus among </text>
  <text x="310.932,313.868,318.931,322.921,325.106,327.291,329.818,335.005,339.347,343.337,346.709,349.645,352.172,356.504,360.646,363.581,368.493,371.979,375.352" y="442.946" svg_rhmargin="377.632" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">the investigators.</text>
  <text x="310.932,318.518,325.021,330.978,334.235,337.491,341.82,347.778,350.761,356.718,361.593,366.468,372.426,377.301,382.176,391.926,397.883,404.386" y="472.962" svg_rhmargin="408.715" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Quality assessment</text>
  <text x="310.932,316.689,321.753,325.743,327.928,329.092,333.234,338.364,341.299,346.363,351.274,354.761,358.133,360.318,361.482,366.612,369.984,373.974,378.99,381.175,382.339,385.274,390.338,394.328,396.513,397.677,401.79,408.051,412.962,416.924,421.987,425.474,429.616,434.803,438.793,440.978,442.141,447.205,451.347,456.534,461.55,466.442,471.354,476.265,480.92,483.105,484.269,487.072,491.983,495.47,497.65500000000003,498.818,502.191,506.437,509.81,512.745,516.735,524.563,528.705,531.641,534.168,538.129" y="490.962" svg_rhmargin="540.314" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The authors used the “Cochrane handbook for systematic </text>
  <text x="310.932,314.419,318.409,322.75,325.277,329.267,335.708,339.081,341.266,343.774,348.685,351.488,353.673,356.181,358.708,363.895,366.83,370.82,374.307,378.648,382.638,387.825,390.761,393.288,398.199,403.386,406.759,408.944,411.452,415.793,419.783,423.27,426.642,429.169,434.081,439.268,441.453,443.961,447.476,452.036,455.551,457.736,460.244,464.804,467.084,471.644,473.924,478.484,482.597,484.782,487.29,490.226,495.137,497.322,499.83,503.972,507.345,510.717,514.707,518.08,521.452,523.637,526.145,529.081,534.144,538.134" y="502.961" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">reviews of interventions version [8] 5.0.0” to assess the </text>
  <text x="310.932,318.76,322.75,325.686,330.749,335.661,340.677,345.588,347.982,352.894,357.226,359.753,363.714,367.856,370.25,372.435,377.261,382.125,387.255,391.397,393.791,396.318,399.254,403.5,405.685,410.511,415.423,418.225,420.41,425.236,428.172,433.235,437.225,439.41,444.236,446.763,451.95,455.912,458.306,463.436,468.452,472.442,477.458,479.64300000000003,484.469,490.378,496.638,502.395,505.768,508.048,510.233,515.059,521.5,526.563,529.09,533.052,538.115" y="514.9590000000001" svg_rhmargin="540.3" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">methodological quality of the included RCTs, which </text>
  <text x="310.932,315.074,318.447,321.819,325.809,329.182,332.554,336.544,341.56,343.84,346.025,347.849,351.364,353.891,357.406,359.591,361.415,365.747,369.737,374.924,378.914,382.401,386.543,389.478,392.005,396.917,402.104,404.289,406.113,411.024,413.827,416.012,417.836,420.771,425.835,429.825,432.01,433.834,437.32,441.462,446.649,451.665,456.577,464.405,466.59,468.414,472.556,474.95,477.344,482.255,486.217,490.359,493.294,495.821,500.733,505.92,508.105,509.929,513.301,517.263,522.326,526.316,534.144,538.134" y="526.9580000000001" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">assessed: (i) generation of the random allocation scheme </text>
  <text x="310.932,314.447,317.934,322.076,327.263,332.279,337.19,345.018,347.374,350.747,354.737,359.601,364.731,368.721,373.908,377.869,381.859,384.215,388.547,392.537,397.724,401.714,405.201,409.343,412.278,414.805,419.717,424.904,428.419,430.699,433.055,436.57,439.097,441.624,445.139,447.495,451.637,454.031,456.425,461.336,465.298,469.44,472.375,474.902,479.814,485.001,487.357,491.318,496.23,501.417,505.378,509.368,513.51,515.904,523.732,527.722,532.909,535.845,538.125" y="538.956" svg_rhmargin="540.31" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">(random sequence generation); (ii) allocation concealment; </text>
  <text x="310.932,314.447,316.974,319.501,322.028,325.543,327.728,329.467,334.359,336.753,339.28,344.467,349.483,352.01,357.197,361.529,363.714,365.453,370.364,373.167,375.352,377.09,382.106,386.248,389.735,392.67,395.197,399.159,401.686,406.702,410.844,416.031,418.966,422.339,424.524,426.262,430.404,435.591,440.607,442.79200000000003,444.531,449.547,453.537,457.023,460.396,465.307,470.494,475.681,479.671,482.065,484.345,486.53000000000003,488.269,491.784,494.311,498.652,502.167,504.352,506.091,510.983,513.377,515.904,521.091,526.107,528.634,533.821,538.153" y="550.955" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">(iii) blinding of participants and personnel; (iv) blinding </text>
  <text x="310.932,315.844,318.646,320.831,321.758,326.669,331.799,334.735,338.696,343.608,351.436,355.426,357.611,358.537,362.679,366.051,369.424,373.414,376.786,380.159,387.987,391.977,397.164,400.099,402.379,404.564,405.49,409.005,413.347,416.862,419.047,419.973,422.5,427.687,431.649,436.56,444.388,449.404,451.798,455.788,458.724,462.714,464.899,465.83,470.741,475.871,478.807,482.768,487.68,495.508,499.498,501.683,502.609,507.625,511.767,514.702,518.844,521.124,523.309,524.236,527.751,532.092,534.619,538.134" y="562.953" svg_rhmargin="540.319" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">of outcome assessment; (v) incomplete outcome data; (vi) </text>
  <text x="310.932,314.305,318.295,320.689,324.679,328.64,331.576,334.103,338.444,342.434,344.619,346.804,350.291,354.281,359.297,364.208,367.695,370.63,373.157,378.344,382.676,384.956,387.141,389.326,393.468,398.655,403.671,405.856,408.041,411.556,415.898,418.425,420.952,424.467,426.652,428.837,433.748,436.684,441.747,445.737,449.224,451.409,453.594,456.966,461.878,467.008,470.494,474.456,478.446,481.818,484.003,486.188,491.1,493.902,496.087,498.272,503.165,505.692,509.834,513.206" y="574.952" svg_rhmargin="515.486" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">selective reporting; and (vii) other sources of bias.</text>
  <text x="310.932,316.89,321.219,327.176,331.505,334.761,339.636,343.965,347.222,352.097,358.054,361.311,364.294,374.044,380.001,384.33,390.834,397.347,403.86" y="604.962" svg_rhmargin="408.735" style="fill:#171615;font-family:PMDSJO+Frutiger-Black;font-size:9.75px;font-style:NORMAL;font-weight:bold;">Statistical methods</text>
  <text x="310.932,316.689,321.753,325.743,327.928,329.267,334.283,338.425,341.361,345.503,347.688,349.027,355.468,359.458,362.945,366.935,369.12,370.459,374.601,379.788,383.93,386.324,390.571,394.475,398.465,403.481,405.666,407.006,412.136,415.508,418.035,423.222,427.554,429.739,431.079,436.988,440.978,445.319,447.846,451.836,458.277,460.462,461.802,470.285,474.427,479.614,483.756,488.088,492.078,495.565,497.75,499.089,503.431,505.711,510.271,512.551,517.111,519.2959999999999,520.635,524.008,528.919,531.722,534.657" y="622.962" svg_rhmargin="538.125" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">The data were analyzed using Review Manager v.5.3 soft-</text>
  <text x="310.932,317.373,321.515,325.002,328.992,331.177,334.549,338.064,344.325,349.236,353.198,358.261,361.748,365.89,371.077,375.067,377.252,380.624,386.885,391.796,394.19,396.584,400.726,405.619,410.53,414.017,418.159,421.094,423.621,428.533,433.72,436.0,438.185,441.557,448.635,453.09,455.893,460.804,464.291,469.307,471.587,473.772,477.144,484.07,490.311,493.826,496.011,499.384,503.526,508.713,513.729,515.914,519.286,523.808,529.109,533.631,538.153" y="634.961" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">ware (Cochrane Collaboration, Oxford, UK) and SPSS </text>
  <text x="310.932,315.492,320.052,322.332,326.892,329.172,331.357,332.801,337.694,342.605,346.092,348.277,349.721,354.737,357.264,361.225,366.289,371.2,374.136,379.047,386.875,391.787,396.917,400.289,402.474,403.918,408.26,412.402,415.888,418.415,422.557,427.45,429.844,433.834,437.206,439.486,441.671,443.115,448.027,453.157,456.092,460.054,464.965,472.793,476.783,480.156,482.341,483.785,490.226,494.216,497.702,501.692,503.877,505.321,508.808,512.798,517.814,522.725,526.212,529.147,533.137,538.153" y="646.9590000000001" svg_rhmargin="540.338" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">16.0. For dichotomous variables, outcomes were reported </text>
  <text x="310.932,315.074,318.447,320.632,323.335,326.821,330.811,333.205,337.347,340.283,342.81,347.151,351.141,353.326,356.029,359.515,362.042,365.415,370.07,372.255,374.957,378.444,382.586,385.521,388.048,392.96,395.145,397.847,401.362,407.271,413.18,416.695,418.88,421.583,425.725,430.912,435.928,438.113,440.814,445.374,449.934,457.952,460.137,462.84,466.802,471.713,476.9,482.097,487.113,491.103,496.29,500.251,504.241,506.426,509.129,511.656,516.843,519.778,523.768,527.255,531.596,535.738,538.132" y="658.958" svg_rhmargin="540.317" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">as relative risk ratio (RR) and 95% confidence interval </text>
  <text svg_rhmargin="342.145" x="310.932,314.447,320.708,323.9,327.415,329.695,331.88,333.832,339.96,342.145" y="670.956" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">(CI). A </text>
  <text x="344.097" y="670.956" svg_rhmargin="349.313" style="fill:#171615;font-family:FXDKZI+Minion-Italic;font-size:9.5px;font-style:ITALIC;font-weight:normal;">P</text>
  <text x="349.312,352.78,352.78,357.121,361.263,363.657,368.787,372.777,374.962,376.914,381.825,384.628,386.813,388.765,394.626,399.186,401.466,406.026,410.586,412.771,414.724,421.165,425.307,428.679,430.864,432.816,436.778,441.689,446.876,450.249,452.776,457.792,461.782,465.268,469.258,474.274,476.459,478.411,481.783,484.719,488.861,491.796,494.323,497.696,500.631,503.158,507.12,511.262,513.656,516.049,520.296,522.481,524.433,527.806,530.333,534.665" y="670.956" svg_rhmargin="538.133" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">- value of &lt;0.05 was considered statistically sig-</text>
  <text x="310.932,316.119,318.646,323.843,327.804,331.946,337.133,340.069,342.349,344.534,346.789,352.546,357.61,361.6,363.785,366.04,371.103,375.093,378.029,382.019,385.505,390.417,394.749,398.739,403.926,407.916,410.443,413.378,417.625,419.81,422.065,425.001,428.991,432.363,435.299,437.484,439.74,446.181,448.708,451.643,456.707,458.892,461.148,463.675,468.862,472.824,477.735,482.922,486.295,488.822,492.194,495.13,499.12,504.307,508.268,512.515,514.6999999999999,516.955,519.482,524.669,529.685,533.675,538.13" y="682.955" svg_rhmargin="540.315" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">nificant. The heterogeneity test with inconsistency index </text>
  <text x="310.932" y="694.953" svg_rhmargin="314.447" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">(</text>
  <text x="314.447" y="694.953" svg_rhmargin="317.592" style="fill:#171615;font-family:FXDKZI+Minion-Italic;font-size:9.5px;font-style:ITALIC;font-weight:normal;">I</text>
  <text x="317.592" y="691.799" svg_rhmargin="321.012" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:7.13px;font-style:NORMAL;font-weight:normal;">2</text>
  <text svg_rhmargin="380.567" x="321.012,324.527,326.712,329.927,333.3,336.235,340.377,343.313,345.84,349.212,352.148,354.675,358.636,360.821,364.037,368.179,373.366,378.382,380.567" y="694.962" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">) statistic and </text>
  <text x="383.778" y="694.962" svg_rhmargin="390.675" style="fill:#171615;font-family:FXDKZI+Minion-Italic;font-size:9.5px;font-style:ITALIC;font-weight:normal;">Q</text>
  <text y="694.962" svg_rhmargin="540.314" x="396.076,399.448,402.384,406.526,409.461,411.988,415.361,418.296,420.823,424.785,426.97,430.186,436.627,440.769,444.141,446.326,449.542,454.558,458.548,462.034,464.837,469.748,473.235,481.063,485.053,490.069,492.254,495.474,498.989,503.549,507.064,509.344,511.529,514.745,517.937,520.74,522.925,526.14,529.076,534.139,538.129" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">statistic was performed [9]. If the </text>
  <text x="310.932,315.844,320.974,323.909,327.871,332.782,340.61,344.6,347.973,350.158,350.908,357.349,361.339,364.826,368.816,371.001,371.751,374.554,379.465,384.595,389.782,394.798,396.983,397.734,400.669,405.581,407.766,408.516,413.579,417.721,422.063,426.053,428.238,428.988,433.32,438.232,443.143,448.159,450.344,451.095,456.158,461.07,468.898,473.809,478.141,482.131,487.318,491.308,493.835,496.771,501.017,503.202,503.953" y="706.961" svg_rhmargin="507.468" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">outcomes were found to have good homogeneity (</text>
  <text x="507.468" y="706.961" svg_rhmargin="512.684" style="fill:#171615;font-family:FXDKZI+Minion-Italic;font-size:9.5px;font-style:ITALIC;font-weight:normal;">P</text>
  <text y="706.961" svg_rhmargin="540.281" x="515.619,521.48,523.665,524.416,528.976,531.256,535.816,538.096" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">&gt; 0.1; </text>
  <text x="310.932" y="718.9590000000001" svg_rhmargin="314.077" style="fill:#171615;font-family:FXDKZI+Minion-Italic;font-size:9.5px;font-style:ITALIC;font-weight:normal;">I</text>
  <text x="314.077" y="715.799" svg_rhmargin="317.497" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:7.13px;font-style:NORMAL;font-weight:normal;">2</text>
  <text style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="319.682" y="718.962" x=""/>
  <text x="321.905" y="718.962" svg_rhmargin="327.121" style="fill:#171615;font-family:DUZYXM+SymbolMT;font-size:9.5px;font-style:NORMAL;font-weight:normal;">≤</text>
  <text y="718.962" svg_rhmargin="540.31" x="331.528,336.088,340.648,348.666,352.181,354.461,356.646,358.869,363.011,365.196,367.419,372.616,377.071,381.061,386.077,388.262,390.485,394.475,397.278,400.08,404.07,408.032,410.967,413.152,415.375,423.203,428.115,433.13,437.12,439.514,441.699,443.922,450.363,454.505,457.878,460.063,462.286,467.416,470.788,474.778,479.794,481.979,484.202,487.005,491.916,495.403,497.588,499.811,503.183,507.173,511.135,516.046,521.233,526.249,530.391,533.878,538.125" style="fill:#171615;font-family:ONOMVQ+Minion-Regular;font-size:9.5px;font-style:NORMAL;font-weight:normal;">50%), a fixed effect model was used for secondary </text>
 </g>
</svg>
